You are here:
Home
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood and bone marrow cancers
Alpha-1 antitrypsin for treating high-risk acute graft-versus-host disease after a haematopoietic stem cell transplant in people 12 years and over [TSID12036]
Awaiting development
Reference number:
GID-TA11596
Expected publication date: TBC
Project information
Project documents
Documents
Documents created during the development process.
Topic selection
Topic selection
Back to top